Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL5069703

CCCC[N+](CCCC)(CCCC)CCCC.[Au]

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SLC22A1 O15245 4/20 0.92
▸ SLC22A2 O15244 1/20 0.79
▸ TSHR P16473 2/20 0.69
▸ ALDH1A1 P00352 1/20 0.69
▸ TP53 P04637 1/20 0.69
▸ CYP3A4 P08684 1/20 0.69
▸ ALOX15 P16050 1/20 0.69
▸ ALOX12 P18054 1/20 0.69
▸ SMN1; SMN2 Q16637 1/20 0.69
▸ HIF1A Q16665 1/20 0.69
▸ HSD17B10 Q99714 1/20 0.69
▸ DNM1 Q05193 6/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL27943583 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL3169343 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL22384 0.96 SLC22A1 (1.00) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL2007037 0.96 SLC22A1 (1.00) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL71525 0.96 SLC22A1 (1.00) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL25195464 0.92 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL21980 0.92 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL7960336 0.92 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL1250868 0.92 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL4260120 0.92 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1958951-A1 PHOSPHINE TRANSITION METAL COMPLEX, METHOD FOR PRODUCING SAME AND ANTITUMOR AGENT CONTAINING SAME Nippon Chemical Industrial Co., Ltd. (JP) 2008-08-20 — — EP disclosed
Send feedback